Cannabis Oil for Pain Effectiveness

Official Title

Cannabis Oil for Pain Effectiveness


This project represents a first systematic, prospective, single-arm cohort study of a safe and effective dosing regimen of an orally administered cannabis oil formulation in a cancer subject population with poorly controlled pain.

Trial Description

Primary Outcome:

  • Sustained pain response
Secondary Outcome:
  • Pain response at any time
  • Toxicity of treatment intervention - incidence and grade of AEs
  • Anxiety and depression
  • Functional well-being
  • Quality of life change
  • Neuropathic pain
Over a 1-2 year period, 40 cancer patients experiencing poorly controlled pain will be enrolled in to a prospective single-arm cohort study, in which they will receive an orally administered cannabis oil formulation as an add-on therapy to current treatment regimens. Subjects entering the acute study phase will be titrated to a tolerated dose at which a sustained pain response is reached, and may subsequently enter a 12 week chronic phase during which safety and durability of pain response will be assessed at their stable dose.

View this trial on

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society